Carregant...

COVID-19 antibodies on trial

With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Biotechnol
Autor principal: DeFrancesco, Laura
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group US 2020
Matèries:
Q&A
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7576980/
https://ncbi.nlm.nih.gov/pubmed/33087898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41587-020-0732-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!